Litcius/Paper detail

Bevacizumab in High-Risk Corneal Transplantation

Thomas H. Dohlman, Matthew J. McSoley, Francisco Amparo, Tatiana Carreno-Galeano, Mengyu Wang, Mohammad H. Dastjerdi, Rohan Bir Singh, Giulia Coco, Antonio Di Zazzo, Hasanain Shikari, Ujwala S. Saboo, Kimberly C. Sippel, Jessica Ciralsky, Sonia H. Yoo, Matheus Sticca, Tais Hitomi Wakamatsu, Somasheila Murthy, Pedram Hamrah, Ula V. Jurkunas, Joseph B. Ciolino, José Álvaro Pereira Gomes, Victor L. Perez, Jia Yin, Reza Dana

2022Ophthalmology30 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBevacizumabHazard ratioPlaceboCorneal transplantationRandomized controlled trialSurgeryTransplantationConfidence intervalPost-hoc analysisOphthalmologyInternal medicineChemotherapyPathologyAlternative medicineCorneal Surgery and TreatmentsCorneal surgery and disordersOcular Infections and Treatments
Bevacizumab in High-Risk Corneal Transplantation | Litcius